What is the role of participation in a clinical trial in the treatment of mycosis fungoides/Sezary syndrome (MF/SS) non-Hodgkin lymphoma (NHL)?

Updated: Jun 12, 2019
  • Author: Priyank P Patel, MD; Chief Editor: Emmanuel C Besa, MD  more...
  • Print


Participation in a clinical trial as a treatment option for all patients with SS or advanced-stage MF is recommended by both the NCCN and EOTRTC. [26, 2] Treatment for SS or erythrodermic MF (stage IV) is palliative. The preferred modality is ECP, either alone or in combination with other treatments. [26, 27, 2]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!